M

Active Director Designated Partner DIN 09365657
DIN 09365657 First appointment Oct 2021 Primary industry Chemicals
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 2 active board seats
Total affiliations 2 Since Oct 2021
Shareholding value β€’β€’β€’β€’ Premium profile

About Mini

Data last updated:

Mini is a Designated Partner at Ayus Pharma Llp (since 2021) and Designated Partner at Ayushpot Llp (since 2021). The companies operate in Chemicals.

DIN 09365657
Primary Designation Designated Partner
Industry Chemicals
First Appointment 20 Oct 2021
Oldest Company Age 5 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Ayus Pharma Llp AAZ-3568
Designated Partner03 Nov 20212021Active
Ayushpot Llp AAZ-0895
Designated Partner20 Oct 20212021Active

Board colleagues of Mini

NameDINCompanyDesignation
Parambil Abdul Gafoor09388454Ayus Pharma LlpDesignated Partner
Sajeesh Parambath09365658Ayushpot LlpDesignated Partner

Directorship timeline

Open interactive timeline →
Ayushpot Llp
Ayus Pharma Llp
Premium access

Shareholding and investment profile for Mini

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Mini

Mini currently holds 2 directorships: Ayus Pharma Llp (Designated Partner, since 03 Nov 2021); Ayushpot Llp (Designated Partner, since 20 Oct 2021).

Mini was first appointed on 20 Oct 2021 as Designated Partner at Ayushpot Llp.

The current boards of Mini's companies include Parambil Abdul Gafoor (Ayus Pharma Llp), Sajeesh Parambath (Ayushpot Llp).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available